BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9838902)

  • 1. [New molecular prognostic markers in gastric carcinoma].
    Yoshida K; Yasui W; Yokozaki H; Nishimoto N; Kagawa Y; Toge T; Tahara E; Yoshida T; Terada M
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2021-7. PubMed ID: 9838902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.
    Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I
    Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplified genes in cancer in upper digestive tract.
    Yoshida T; Sakamoto H; Terada M
    Semin Cancer Biol; 1993 Feb; 4(1):33-40. PubMed ID: 8095412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
    Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
    Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of K-sam protein in stomach cancer.
    Hattori Y; Itoh H; Uchino S; Hosokawa K; Ochiai A; Ino Y; Ishii H; Sakamoto H; Yamaguchi N; Yanagihara K; Hirohashi S; Sugimura T; Terada M
    Clin Cancer Res; 1996 Aug; 2(8):1373-81. PubMed ID: 9816310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanisms of carcinogenesis in human stomach cancer: K-sam gene].
    Yoshida K; Toge T; Kuniyasu H; Yasui W; Tahara E
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():53-9. PubMed ID: 11424439
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological significance of gene amplification in carcinogenesis.
    Terada M; Sakamoto H; Ohmura Y; Tsuruta H; Akiyama N; Sasaki H; Katoh M; Hattori Y; Yoshida T
    Princess Takamatsu Symp; 1991; 22():371-80. PubMed ID: 1844251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multistep stomach carcinogenesis].
    Yokozaki H; Tahara E
    Nihon Rinsho; 1996 Apr; 54(4):1066-71. PubMed ID: 8920675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
    Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
    Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is tumor size a prognostic indicator for gastric carcinoma?
    Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
    Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
    Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
    Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the carboxyl-terminal exons of K-sam/FGFR2 by short homology-mediated recombination, generating preferential expression of specific messenger RNAs.
    Ueda T; Sasaki H; Kuwahara Y; Nezu M; Shibuya T; Sakamoto H; Ishii H; Yanagihara K; Mafune K; Makuuchi M; Terada M
    Cancer Res; 1999 Dec; 59(24):6080-6. PubMed ID: 10626794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of growth factor receptor genes and DNA ploidy pattern in the progression of gastric cancer.
    Tsujimoto H; Sugihara H; Hagiwara A; Hattori T
    Virchows Arch; 1997 Dec; 431(6):383-9. PubMed ID: 9428926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.